ADAP
Adaptimmune Therapeutics
ADAP
ADAP
88 hedge funds and large institutions have $134M invested in Adaptimmune Therapeutics in 2023 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 26 increasing their positions, 11 reducing their positions, and 10 closing their positions.
Holders
88
Holders Change
+23
Holders Change %
+35.38%
% of All Funds
1.39%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
33
Increased
26
Reduced
11
Closed
10
Calls
$25K
Puts
$70K
Net Calls
-$45K
Net Calls Change
-$28K